GXO Logistics (GXO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 May, 2026Executive summary
Supplemental disclosure provided for Proposal 3, the advisory vote on executive compensation at the 2026 Annual Meeting scheduled for May 20, 2026.
Details shared regarding the CEO transition process, emphasizing leadership continuity and protection of stockholder value.
The Board, with external assistance, conducted a thorough CEO search, resulting in Patrick Kelleher's appointment and a structured transition from Malcolm Wilson.
Voting matters and shareholder proposals
Proposal 3 seeks stockholder approval of executive compensation (Say-on-Pay), with the Board recommending a vote in favor.
Stockholders are encouraged to engage with the company regarding the CEO transition and compensation matters prior to the Annual Meeting.
Board of directors and corporate governance
The Board prioritized stability, continuity, and protection of institutional knowledge during the CEO transition.
Full Board involvement in the CEO search, including both internal and external candidates.
Ongoing commitment to transparent disclosure and responsiveness to investor feedback.
Latest events from GXO Logistics
- Revenue up 11% to $3.3B, net income $5M, and 2026 guidance raised on strong pipeline and AI focus.GXO
Q1 20266 May 2026 - Record revenue, board refreshment, and strong ESG focus highlight this year's proxy.GXO
Proxy filing22 Apr 2026 - Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Apr 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - Record 2024 results and strong 2025 outlook with margin expansion and robust pipeline.GXO
Q4 202415 Dec 2025 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025